SCHEMBL1298514

SCHEMBL1298514

CCOC(=O)C(=O)CCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2319664 0.85 ALDH1A1 (0.42)
SCHEMBL5762176 0.81 ALDH1A1 (0.42)
SCHEMBL14934920 0.81 ALDH1A1 (0.46)
SCHEMBL2085613 0.80 FAAH (0.47)
SCHEMBL5177417 0.80 HCAR2 (0.39)
SCHEMBL10689235 0.80 NPSR1 (0.50)
SCHEMBL10689237 0.80 NPSR1 (0.50)
SCHEMBL4807770 0.78 MAPT (0.39)
SCHEMBL4812377 0.78 MAPT (0.39)
SCHEMBL18501522 0.78 MAPT (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114890932-A First total synthesis process of indole alkaloid Luteoride A 大理大学 2022-08-12 CN claimed
JP-56061328-A None JP disclosed
US-20160332971-A1 ARYLQUINOLINE, ARYLQUINOLONE AND ARYLTHIOQUINOLONE DERIVATIVES AND USE THEREOF TO TREAT CANCER UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION 2016-11-17 US disclosed
US-8889691-B2 Indole compounds as an inhibitor of cellular necrosis LG LIFE SCIENCES LTD. (KR) 2014-11-18 US disclosed
US-20140024618-A1 INDOLE COMPOUNDS AS AN INHIBITOR OF CELLULAR NECROSIS LG LIFE SCIENCES LTD. (KR) 2014-01-23 US disclosed
US-8569307-B2 Indole compounds as an inhibitor of cellular necrosis LG LIFE SCIENCES LTD. (KR) 2013-10-29 US disclosed
EP-2178869-B1 INDOLE COMPOUNDS AS AN INHIBITOR OF CELLULAR NECROSIS LG LIFE SCIENCES LTD (KR) 2013-06-12 EP disclosed
WO-2013045495-A1 PYRANO[3,2-c][2]BENZOPYRAN-6(2H)-ONE DERIVATIVES AND USES THEREOF PROUS INSTITUTE FOR BIOMEDICAL RESEARCH, S.A. (ES) 2013-04-04 WO disclosed
EP-2573088-A1 Pyrano[3,2-c]benzopyran-6(2h)-one derivatives and uses thereof Prous Institute for Biomedical Research, S.A. (ES) 2013-03-27 EP disclosed
US-8404677-B2 Kinase inhibitors GENOSCO (US) 2013-03-26 US disclosed
WO-2008014311-A2 INHIBITORS OF UNDECAPRENYL PYROPHOSPHATE SYNTHASE NOVARTIS AG (CH) 2008-01-31 WO disclosed
EP-1786411-A2 3-HALO-2-OXOPROPIONATE SALTS AND ESTERS AS NOVEL ANTICANCER AGENTS Board of Regents, The University of Texas System (US) 2007-05-23 EP disclosed
US-20060287356-A1 dietetics or antidiabetic agents such as 4-hydroxy-3-(4'-hydroxy-1,1'-biphenyl-4-yl)-6-oxo-6,7-dihydrothieno[2,3-b]pyridine-5-carbonitrile, used for prophylaxis of metabolic disorders IYENGAR RAJESH R 2006-12-21 US disclosed
US-7119205-B2 Thienopyridones as AMPK activators for the treatment of diabetes and obesity ABBOTT LABORATORIES (US) 2006-10-10 US disclosed
US-20060058383-A1 Propyl 3-bromo-2-oxopropionate and derivatives as novel anticancer agents BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2006-03-16 US disclosed
WO-2006020403-A2 3-HALO-2-OXOPROPIONATE SALTS AND ESTERS AS NOVEL ANTICANCER AGENTS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2006-02-23 WO disclosed
US-20050038068-A1 Thienopyridones as AMPK activators for the treatment of diabetes and obesity ABBVIE INC. 2005-02-17 US disclosed
US-5670508-A ANTITUMOR AGENTS FOR BRAIN TUMORS NATIONAL SCIENCE COUNCIL (TW) 1997-09-23 US disclosed
US-4560690-A ANTISECRETORY AGENTS, HISTAMINE H2-ANTAGONISTS PFIZER INC. (US) 1985-12-24 US disclosed
JP-S5661328-A PURIFICATION OF HALOGENATED PYRUVIC ESTER SEITETSU KAGAKU CO LTD 1981-05-26 JP disclosed